Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma

Figure 3

Correlation of plasma miRNA-216a/b with lymph node metastasis and TNM stage. Patients with lymph node metastasis exhibited significantly lower plasma miRNA-216b expression level than those without lymph node metastasis (b), while no significant difference was found in miRNA-216a (a). Patients with TNM IV exhibited significantly lower plasma miRNA-216a expression level than those with TNM 0-I or II (c). Patients with TNM III exhibited significantly lower plasma miRNA-216b expression level than those with TNM 0-I (d).

(a)

(b)

(c)

(d)